| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |